Saturday, October 16, 2021

Iconic buildings and monuments illuminated in blue for World Pneumonia Day

Famous buildings and monuments turned blue this month in a Pfizer-sponsored effort to raise pneumonia awareness. From Trafalgar Bridge in Australia to Niagara Falls in Canada, more than 250 well-known structures in 52 countries were lit up in a brilliant blue hue on Nov. 12.

Pfizer collaborated with the Hospital Clinic of Barcelona and the Every Breath Counts Coalition to commemorate World Pneumonia Day and raise awareness around the problem of pneumonia.

The visual display is the start of PneumoLight, a five-year campaign to spread factual information about the disease. Catia Cillóniz, Ph.D., a medical researcher at the University of Barcelona’s hospital clinic, personally sent 3,000 emails to mayors and directors of organizations around the world detailing information about pneumonia in order to persuade them to join the project and light the buildings or monuments blue.

On-Demand Webinar

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research. Sign up today for this informative webinar to learn how you can leverage one of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.

RELATED: Argenx lights up bridges, teases documentary in myasthenia gravis awareness push

“The color blue represents medicine, air and health. I am a health worker and I have witnessed such high mortality at the beginning of the pandemic due to pneumonia caused by COVID-19. This motivated me a lot to make this project come true,” she said in an email interview. 

Even before COVID-19’s assault on people’s lungs, pneumonia was a huge problem for children and adults worldwide. More than 2.5 million people died from pneumonia in 2019, including 672,000 children and 1.2 million adults over the age of 70, according to the Global Burden of Disease project.

Pfizer has been working with Cillóniz on conferences for World Pneumonia Day since 2018, and this year the company provided funding for the organization of the virtual global conference.

RELATED: Pfizer execs see blockbuster opportunities throughout vaccine pipeline, beyond pneumonia and COVID-19

“There is a lot of work to do to make an impact on this disease. I would like people to understand that it can be prevented, that you have to get vaccinated and understand why we get vaccinated. Only by understanding all this will we achieve any impact regarding this disease,” Cillóniz said.

Pfizer’s pneumococcal vaccine, Prevnar 13, is the world’s bestselling vaccine, with sales of $5.85 billion last year. The company is getting closer to filing for the latest iteration, Prevnar 20, which will compete with investigational Merck rival V114, a 15-valent shot.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...